<< Researchers discover why Lou Gehrig's disease speeds along more rapidly in some patients than others | Washington Independent examines U.S. food aid >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Ελληνικά | Русский | Svenska | Polski

WHO to incorporate disease severity into pandemic alert scale

Published on June 9, 2009 at 3:02 AM · No Comments

A meeting of the WHO's emergency committee held Friday to discuss the H1N1 (swine) flu ended without a pandemic declaration, but experts concluded that declarations would now be based upon the severity and transmission pattern of a virus, Reuters reports (Nebehay, Reuters, 6/5). "The Emergency Committee is composed of international experts and its task is to give advice to the WHO chief on influenza outbreak responses," according to Xinhua writes (Xinhua, 6/6).

"There was a broad consensus on the importance of including information on severity in future announcements," explained the WHO in a statement released after Friday's meeting. According to Reuters, "The experts … made recommendations on a number of factors to be taken into account to assess the severity of an epidemic, it said, without giving details."

The committee "maintained their advice against closing borders or restricting international travel to try to halt the continued spread of the H1N1 influenza virus, measures deemed ineffective" and also sustained support for seasonal flu vaccine production "as work proceeds on developing a vaccine against the new strain," Reuters writes. WHO officials said deciding whether to raise the pandemic alert system to phase 6 – signifying H1N1 to be a pandemic – was not "on the formal agenda" (Reuters, 6/5).

The WHO on Monday confirmed that 73 countries have officially reported 25,288 cases of influenza A(H1N1) infection, including 139 deaths. A full list of country cases and deaths is available here (WHO Influenza A(H1N1) – update 45, 6/8).

New CDC Director Discusses H1N1, 'Winnable Battles In Global Health'

When CDC director Thomas Frieden assumes his new post as the director of the CDC on Monday, one of his continued focuses will be to track the spread of H1N1 in the U.S. and support similar efforts around the world, the Wall Street Journal reports.

"The former New York City health commissioner has been on the front lines of a local H1N1 outbreak that as of Friday had been linked to the deaths of eight people and hundreds of hospitalizations. Dr. Frieden now faces the challenge of helping guide the national response to the virus, while strengthening the CDC's scientific programs and carving out a sizable role for it in the Obama administration's broader health-care overhaul effort," the Wall Street Journal writes.

"There are still lots of unanswered questions [regarding H1N1 flu] – its case fatality rate, vaccine efficacy, the potential impact on the elderly," Frieden said, adding, "The key is getting data; one of the most important things is global data." The CDC is helping to support the efforts of global health officials tracking the spread of H1N1.

"He said he saw a strong role for the CDC in global health. The agency helps global health officials track diseases, investigate outbreaks and strengthen public-health programs around the world," Wall Street Journal writes. "There are a lot of winnable battles in global health," Frieden said (McKay, Wall Street Journal, 6/6).

Bipartisan Commission Says Diverting Biological Attack Preparedness Funds For H1N1 'Will Leave Nation Less, Not More, Prepared'

The Washington Post examines the arguments of the bipartisan Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism that President Obama's recent request to support the production of a swine flu vaccine with "funds set aside to develop defenses against biological attacks would weaken the nation's preparedness for terrorism" written in a letter sent to Obama sent Sunday.

The letter comes less than a week after the White House asked Congress "for authority to spend up to $9 billion more for an H1N1 flu vaccine and other preparations against the novel flu strain that first appeared in April," the Washington Post writes.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading